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Abstract
A 52-year-old subject harboring an RS1 gene W112C mutation presented with a prominent and asymmetric tapetal-like retinal sheen.
Transient ERG responses were smaller and slower in the eye with the more extensive sheen, an association that, to our knowledge, had
not been previously reported. An ON-pathway dysfunction explained the abnormalities of the transient but not those of the Xicker ERGs.
Although in vitro studies showed that the W112C mutant retinoschisin is present only in the cellular fraction and is not secreted, disease
expression was remarkably mild, consistent with the notion of the existence of genetic and/or epigenetic disease modiWers.
© 2006 Elsevier Ltd. All rights reserved.
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X-linked recessive juvenile retinoschisis (XLRS) is a
hereditary retinal disease characterized by splitting of the
neuroretina, resulting from mutations in the RS1 gene
(Sauer et al., 1997). Over the past few years, the cellular
localization and molecular characterization of the 224-
amino acid protein encoded by RS1, retinoschisin, has been
partially elucidated, suggesting a role in retinal cell adhe-
sion (Molday, Hicks, Sauer, Weber, & Molday, 2001; Reid,
Yamashita, & Farber, 2003; Weber et al., 2002; Wu & Mol-
day, 2003), and revealing an important role in synaptic
transmission at the bipolar cell level (Molday et al., 2001;
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into the clinical, functional, and pathologic features of
XLRS. In its most typical clinical manifestations, XLRS is
characterized by foveal stellate cystic changes, causing
reduced visual acuity in childhood, and peripheral retinos-
chisis (Falcone & Brockhurst, 1993; George, Yates, &
Moore, 1995, 1996; Kellner, Brummer, Foerster, & Wes-
sing, 1990). Among the less common manifestations is a
tapetal-like, silver to golden patchy reXex, which has been
reported in up to 38% of cases (George, Yates, & Moore,
1996). Although it has been hypothesized that this reXex
may be due to excess extracellular K+ ions, either resulting
from excessive release from activated retinal neurons or
from impaired Müller cell K+ reuptake (de Jong, Zrenner,
van Meel, Keunen, & van Norren, 1991), its true biological
signiWcance remains unknown.
Here, we report the case of a man with unusually late-
onset and mild visual symptoms associated with a distinctive
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mentioned prominent retinal tapetal-like metallic reXexes,
accompanied by functional manifestations at the ERG level
that paralleled the extent of the sheen, and in whom a RS1
mutation was identiWed, oVering also the opportunity for
biochemical in vitro characterization of the mutant protein.
2. Methods
All studies reported herein conformed to the Declaration of Helsinki
and study protocols were approved by the Institutional Review Boards of
the participating institutions.
2.1. Clinical exam
Family history was collected from the proband at the time of examina-
tion, along with a standard questionnaire for patients with hereditary retinal
diseases. Visual acuity was measured by means of conventional Snellen
charts in a clinical setting. Undilated and dilated anterior segment exam and
posterior segment exam were conducted by slit lamp biomicroscopy. Scleral
depression under indirect ophthalmoscopy was applied for further evalua-
tion of the retinal far periphery. Digital color photographs of the fundus and
an intravenous Xuorescein angiogram were obtained according to standard
methodologies following maximal pharmacological pupil dilation.
2.2. ERG testing protocol
Full-Weld ERG testing was performed in a clinical setting to ascertain
the functional retinal status of this patient according to a previously
reported protocol (Koenekoop et al., 2002; Pannarale et al., 1996). Tests
were conducted on a day distinct from that of the clinical exam. In brief,
after 30 min of full dark-adaptation and maximal pharmacological pupil
dilation, dark-adapted rod-driven responses were recorded with a
¡2.25log candela [cd] s/m2, 0.5 Hz white strobe Xash, followed by maximal
(mixed rod-cone) dark-adapted (0.5 Hz) and photopic (1 Hz transient and
30 Hz Xicker) light-adapted (steady background of approximately 30 cd/
m2) ERG responses, recorded with a Xash of 0.18log cd s/m2. Monopolar
contact lens electrodes applied under dim red light following topical anes-
thesia were used to measure the responses. Reference and ground elec-
trodes were applied on the forehead midline and one earlobe, respectively.
2.3. Mutation screening
After obtaining from the proband informed consent to molecular
genetic testing for further work-up, whole blood was collected in EDTA-
containing tubes and shipped to the University of Michigan, where geno-
mic DNA was extracted, and all the six exons of the RS1 gene were PCR
ampliWed and subsequently sequenced as previously described (Retinos-
chisis Consortium, 1998).
2.4. Retinoschisin mutants
The human RS1 cDNA was subcloned as described earlier (Wu &
Molday, 2003) into pCEP4 vector (Invitrogen) using the XhoI and HindIII
restriction sites. To introduce the W112C mutation the quick change site-
directed mutagenesis kit (Stratagene) was used. The constructs were
sequenced to verify the desired mutation and the absence of random muta-
tions. The RS1 3R10 mAb (Weber et al., 2002) was puriWed and coupled to
CNBr-activated Sepharose 2B as previously described (Molday, Cook,
Kaupp, & Molday, 1990).
2.5. Cell culture and transfection
EBNA 293 cells (American Type Culture Collection) were transfected
in 10 cm dishes with 20 g of plasmid DNA per dish, containing wildtypeRS1 or the W112C mutation, using the calcium phosphate transfection
procedure as previously described (Wu & Molday, 2003). BrieXy, 500 l of
BBS-buVered saline (50 mM N,N-bis(2-hydroxyethyl)-2-aminoethane,
280 mM NaCl, 1.4 mM Na2PO4, pH 6.95) was added drop-wise to a DNA
solution containing 250 mM calcium chloride and incubated for 20 min at
room temperature. DNA was then added to exponentially growing EBNA
293 cells and incubated at 37 °C under 5% CO2. The DNA containing
medium was replaced with regular medium the next day and the cells and
cell culture supernatant were harvested two days later.
2.6. Protein analysis
Protein extraction, gel electrophoresis and Western blotting were per-
formed essentially as previously described (Wang et al., 2002, 2006; Wu &
Molday, 2003; Wu, Wong, Kast, & Molday, 2005). BrieXy, the cellular
fraction was obtained by washing the cells twice in PBS (137 mM NaCl,
2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4) by low speed centrifu-
gation. The Wnal pellet was re-suspended in 200 l of PBS containing
20 mM N-ethylmaleimide (NEM). Cells were lysed by adding 400 l of
PBS containing 20 mM NEM, 2% Triton X-100 and complete protease
inhibitor (Roche Applied Science). After 1 h at 4 °C the solution was cen-
trifuged at 100,000 g for 10 min and the supernatant was retained for gel
electrophoresis. The secreted fraction was obtained by centrifuging the
supernatant at 15,000 rpm in a Sorvall SS 34 rotor for 20 min to remove
debris. The supernatant was then incubated for 2 h with an immunoaYnity
resin consisting of the RS1 3R10 antibody coupled to Sepharose 2B (Wu
& Molday, 2003). After washing several times with column buVer (20 mM
Tris–HCl, 0.2% Triton X-100, 20 mM NEM), bound RS1 was eluted with
200 l of 4% SDS in column buVer.
Twenty microlitres of each eluted and cellular fraction was used for
SDS gel electrophoresis and Western blotting. Proteins were denatured in
an SDS cocktail (10 mM Tris pH 6.8, 1% SDS, 10% glycerol) in the pres-
ence or absence of 4% -mercaptoethanol and separated on either a 6.5%
(non-reducing conditions) or 10% (reducing conditions) polyacrylamide
gel. Non-reducing and reducing gels were transferred to immobilon-FL for
20 min in transfer buVer (25 mM Tris, 192 mM glycine) containing 20%
methanol. Blots were blocked with 1% skim milk in PBS and labeled with
the RS1 3R10 monoclonal antibody for 1 h and goat anti-mouse Ig conju-
gated to CW800 for 1hour for detection with an Odyssey Infrared Imaging
System (Licor, Lincoln, NE).
3. Results
3.1. Clinical Wndings
A 52-year-old white man of Italian ancestry presented
with a complaint of mildly reduced visual acuity and light
aversion. There were no other visual complaints or relevant
Wndings, except for history of uneventful cataract surgery
one year before the exam. Family history was non-contrib-
utory. None of the patient’s siblings or relatives reported
any eye disease, and the proband had three healthy sons.
The patient’s best-corrected visual acuity was 20/40+2 in the
right eye and 20/30 in the left. The anterior segment exam
was unremarkable, except for presence of intra-ocular
lenses in both eyes. Posterior segment examination showed
a subtly dystrophic macular aspect with a sharply demar-
cated foveal reXex suggestive of possible previous foveal
cystic appearance but no discernible schitic change
(Fig. 1A). This appearance was associated with perifoveal
transmission defects conWguring a faint bull’s eye appear-
ance to retinal angiography (Fig. 1B) in both eyes. No mac-
ular or peripheral schitic changes were seen in either eye,
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lines suggestive of spontaneous resolution of a previous ret-
inal detachment. The mid-peripheral retina was remarkable
for a prominent bilateral patchy golden metallic sheen,
which was much more widespread in the right eye (Fig. 1C),
and Wne mottling of the far-peripheral retinal pigment epi-
thelium (RPE). Vitreous veils, more evident in the left eye
than in the right, were also observed. The patient was not
available for optical coherence tomography (OCT) testing.
3.2. ERG Wndings
Testing was remarkable for electronegative maximal ERG
responses and a signiWcant inter-ocular asymmetry (Figs. 2
and 3). In brief, in addition to the maximal ERG responses b-
wave truncation, ERG responses in the left eye were remark-
able for a mild delay of the mixed a-wave and a marked
reduction in the amplitude of the 30 Hz Xicker ERG, which
was also slightly delayed. Compared to the left eye, the righteye showed: a markedly delayed and subnormal (25%
smaller) rod-driven response; a more delayed and reduced
(nearly 30% smaller) maximal ERG response a-wave and a
delayed and more markedly attenuated b-wave (b/a-wave
ratios: 0.94 in the right eye; 1.02 in the left eye; normal: >1.6);
and a reduced b-wave (50% smaller) and slight delay of the
transient light-adapted photopic ERG. Remarkably, there
was no signiWcant asymmetry in the 30Hz Xicker responses,
which were both markedly attenuated and mildly delayed.
Despite the lack of evidence for X-linked inheritance, the
combination of these clinical and functional Wndings sug-
gested the provisional diagnosis of XLRS.
3.3. Molecular genetic Wndings
To conWrm the diagnostic impression of XLRS at the
molecular level, the six exons of the RS1 gene were
sequenced as previously described (Retinoschisis Consor-
tium, 1998), revealing a G to T change at position 336 ofFig. 1. Representative images of the fundus Wndings. (A) Posterior pole of the right eye of the proband. A dull foveal reXex and a mottled appearance of
the macula were present, but no macular schisis could be observed ophthalmoscopically. (B) Mid-stage and late-stage (inset) Xuorescein angiogram from
the same eye, showing no change in the perifoveal hyperXuorescence, consistent with window defects due to dropout of the perifoveal retinal pigment epi-
thelium, nearly conWguring a bull’s eye maculopathy. (C) View of the superotemporal quadrant of the right eye, illustrating the tapetal-like golden metallic
reXex that was intense throughout the majority of the retinal mid-periphery in all quadrants of this eye. Similar but less prominent Wndings were present in
the periphery of the left eye.Fig. 2. ERG responses from a normal subject and from the XLRS patient harboring the W112C RS1 mutation. Arrows identify Xash onset for transient
stimuli. Vertical calibration bars are for amplitudes in microvolts (V), and horizontal calibration bars are for response timing in milliseconds (ms). DA,
dark-adapted; LA, light-adapted. R, rod-driven; RC, rod/cone-driven (mixed maximal ERG response); C, cone-driven (photopic). Flash intensities are
given for each stimulus condition in log cd second/meter2. OD, right eye; OS, left eye.
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amino acid substitution at codon 112 (p. Trp112Cys, or
W112C). This missense mutation has been reported before
in XLRS patients. The speciWc G ! T change found in our
proband has been thus far reported only in Italian patients
(Retinoschisis Consortium, 1998; Simonelli et al., 2003),
whereas a G ! C change resulting in an identical W to C
amino acid substitution has been reported also in French
and Australian patients (Hewitt et al., 2005; Retinoschisis
Consortium, 1998).
3.4. In vitro characterization of the W112C mutant 
retinoschisin protein
Previous studies have documented that most RS1 muta-
tions result in failure of secretion and intracellular retention
of retinoschisin in the endoplasmic reticulum (ER) (Wang
et al., 2002, 2006; Wu & Molday, 2003). In contrast, a few
mutations result in reduced secretion, while others do not
aVect secretion, but prevent the assembly of retinoschisin into
homo-dimers and homo-octameric complexes, two steps that
are independent of one another (Wang et al., 2002, 2006; Wu
& Molday, 2003; Wu et al., 2005). At the start of this study,
the molecular and cellular properties W112C mutation had
not been studied. Therefore, to gain insight into the mecha-
nism underlying the distinctive clinical and functional pheno-
type of our proband, we expressed RS1 with a W112C
mutation in EBNA 293 cells to determine the abundance of
the retinoschisin protein in the cellular and secreted fractions.
Our results (Fig. 4) demonstrate that the W112C mutant is
expressed at levels similar to wild-type (WT) protein and is
present in the cellular fraction. However, unlike the WT pro-
tein, the W112C mutant fails to be secreted from cells either
as a 24 kDa monomer or a higher molecular weight homo-
octameric complex.4. Discussion
The case of this patient highlights the importance of
considering the diagnosis of XLRS whenever clinical and/
or functional manifestations support such diagnosis also in
the absence of clear-cut X-linked inheritance and regardless
Fig. 4. Expression and secretion of wild-type (WT) and W112C mutant
retinoschisin. Cells expressing WT or mutant retinoschisin were separated
into the cellular (cells) and secreted fraction (medium). Retinoschisin in
the secreted fraction was concentrated by immunoprecipitation. The
expressed proteins were fractionated on a 6.5% or 10% SDS–polyacryl-
amide gel under nonreducing and reducing conditions, respectively and
Western blots were labeled with the RS1 3R10 monoclonal antibody.Fig. 3. Plot of ERG amplitudes (A) and timings (B). The open symbols identify the values of the patient aVected with the W112C RS1 mutation: open tri-
angle, right eye (OD); open circle, left eye (OS). The dark horizontal bars identify the upper and the lower limit of the normal range for each parameter for
this laboratory (§ 2 SD). The amplitude plot, in microvolts (V), is presented on a log scale to facilitate resolution of the data points of the aVected subject.
R, rod-driven; RC, rod/cone-driven (mixed maximal ERG response); C, cone-driven (photopic); a-w, a-wave; b-w, b-wave.
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Terasaki, & Miyake, 2001), and emphasizes the beneWts of
molecular veriWcation of the diagnosis, especially with
regard to the counseling of the proband’s three sons. The
Wnding of the previously reported W112C mutation in this
Italian patient resulting from a G ! T nucleotide change
thus far conWrms its uniqueness to subjects of this descent.
4.1. Mild phenotype associated with the W112C mutation: 
Further evidence for phenotypic heterogeneity and modiWers 
in XLRS
Consistent with the impression that XLRS patients
exhibit remarkable phenotypic variability (e.g., Inoue et al.,
2000), the comparison of our Wndings with those of the
other reported patients with the W112C mutation (Hewitt
et al., 2005; Simonelli et al., 2003) conWrms that there is no
simple genotype-phenotype correlation in XLRS. DiVerent
from our patient, both Simonelli et al. (2003) and Hewitt
et al. (2005) reported that all of their patients had macular
schisis and/or atrophy of the RPE, peripheral retinoschisis
in at least one eye, and often retinal detachments. It is
therefore apparent that other genetic and/or epigenetic fac-
tors are likely to act as signiWcant phenotypic modiWers in
XLRS. The identiWcation of the factors that play a deter-
mining role in mild phenotypic manifestations such as
those observed in our patient may have important pathoge-
netic and therapeutic implications for XLRS.
4.2. The W112C mutation causes complete intracellular 
retention of retinoschisin
RS1 mutations can have diVerent eVects on the intrareti-
nal fate of retinoschisin. The main eVect of most mutations
is defective secretion, resulting in complete intracellular
retention at the level of the ER (Wang et al., 2002; Wu &
Molday, 2003). Some mutations, however, cause only par-
tially defective secretion, while others do not aVect it signiW-
cantly, yet they can aVect the assembly of retinoschisin into
homo-dimers and homo-octameric complexes, two steps
that are independent of one another (Wang et al., 2006; Wu
& Molday, 2003; Wu et al., 2005). Because secretion of reti-
noschisin is critical to its function as an extracellular pro-
tein, it was important to determine whether the secretory
mechanism was altered by the W112C mutation.
A structural model of the WT discoidin domain along
with the position of intramolecular disulWde bonds and the
location of the conserved W112 is shown in Fig. 5. The
W112 residue is buried into the discoidin domain structure
with an estimated surface accessibility of only 3%. As a
result, the substitution of a tryptophan with an ectopic cys-
teine residue (W112C) would be predicted to disrupt inter-
actions essential for the proper folding and three-
dimensional structure of its discoidin domain (Fraternali,
Cavallo, & Musco, 2003). Heterologous expression of the
W112C mutant in EBNA 293 cells provides support for this
prediction. The W112C mutant, unlike WT retinoschisin, isretained in the ER by the quality control system of the cell,
which prevents secretion of misfolded proteins. Moreover,
an additional cysteine at position 112 can result in the for-
mation of aberrant intermolecular disulWde bonds resulting
in protein aggregation within the lumen of the ER (Wu &
Molday, 2003). During the course of our studies, Wang
et al. (Wang et al., 2006) extended their in vitro studies of
disease-linked retinoschisin mutants. In this study, they
reported that the W112C mutant fails to be secreted from
COS-7 cells transfected with this mutant, a result that is in
agreement with our studies reported here using EBNA 293
cells.
4.3. ERG abnormalities: a pattern consistent with 
coexistence of ON- and OFF-pathway defects
A defect in photoreceptor-to-bipolar cell synapses or in
bipolar cells themselves likely explains the ERG abnormal-
ities observed in our patient, a Wnding that Wts well with the
expression pattern of retinoschisin (Molday et al., 2001;
Reid et al., 2003; Reid & Farber, 2005; Takada et al., 2004;
Wu & Molday, 2003) and the observed disruption of the
photoreceptor-to-bipolar synapse observed in Rs1h knock-
out mice (Weber et al., 2002). Abnormalities of both ON
and OFF ERG responses have been reported in XLRS
(Alexander, Barnes, & Fishman, 2001a; Alexander, Fish-
man, Barnes, & Grover, 2001b; Khan, Jamison, Kemp, &
Sieving, 2001; Shinoda et al., 2001). Based on the current
understanding of the origin of full-Weld ERG components
Fig. 5. A ribbon model for the discoidin domain of retinoschisin showing
the location of the W112 residue. The discoidin domain of RS1 is shown
to have a barrel-like structure consisting of eight beta strands with spikes
projecting from one end of the structure. The location of W112 (red) and
the C63-C219 and C110-C142 intramolecular disulWde bonds (blue) is
shown. The W112 residue is buried inside the discoidin domain structure,
where it contributes to the folding and structure of the protein. The model
was generated as described by Wu and Molday (2003).
3850 A. Iannaccone et al. / Vision Research 46 (2006) 3845–3852(Bush & Sieving, 1994; Khan et al., 2005; Kondo & Sieving,
2001, 2002; Sieving, Murayama, & Naarendorp, 1994), the
abnormalities observed in the dark-adapted transient ERG
responses of our patient are best explained by a selective or
prevailing dysfunction of depolarizing ON-bipolar cells,
more severe in the right eye. This appears to be case also for
the transient photopic ERG of this patient, which resem-
bled very closely that obtained in monkeys following
ON-pathway blockade (Bush & Sieving, 1994). However,
the bilateral and symmetric marked reduction in the ampli-
tude of the Xicker response is not adequately explained by
an ON-pathway defect.
ERG studies by Kondo and Sieving (Kondo & Sieving,
2002) in primates have shown that the clinical 30 Hz light-
adapted strobe Xash-evoked photopic ERG response
would not be expected to be substantially reduced in ampli-
tude as a result of a selective ON-pathway block. By anal-
ogy (Kondo & Sieving, 2002), we propose that, at least in
response to the stimuli of the type, frequency and intensity
used here, the 30 Hz Xicker symmetrically reduced ampli-
tude is best explained by the coexistence of an OFF-path-
way dysfunction, likely present in both eyes to an
approximately identical extent. This interpretation of the
Xicker ERG results is consistent with the notion that the
Xicker ERG probes the photopic system diVerently than the
transient cone ERG and is in line also with the studies con-
ducted by Khan et al. on other XLRS patients (Khan et al.,
2001).
It remains unclear why would the retinal sheen correlate
only with the degree of ON-pathway compromise and why
would an asymmetry in retinal dysfunction exist only for
the ON- and not the OFF-pathway. A possible answer may
lie in the “push-pull” model with which Sieving et al.
(Sieving et al., 1994) characterized the interaction between
second-order neurons of the ON- and OFF-photopic path-
ways and their eVects on the generation of the photopic
ERG. It must be noted, though, that additional complexi-
ties of the cone pathways have been recently revealed
(Khan et al., 2005). Therefore, yet unknown aspects of the
regulation and responsiveness of retinal microcircuitry may
also account for this observation.
4.4. The tapetal-like metallic reXex in XLRS: a sub-clinical 
disease expression resulting from intracellular retention of 
retinoschisin?
The clinical and functional signiWcance of the tapetal-
like metallic reXex in XLRS is not fully understood. The
tapetal-like sheen observed in our patient was not reported
in any of the XLRS patients described by either Simonelli
et al. (Simonelli et al., 2003) Hewitt et al. (Hewitt et al.,
2005), or in the Wrst report of the W112C mutation (Reti-
noschisis Consortium, 1998). The presence of a tapetal-like
reXex has instead been noted in other XLRS patients with
veriWed RS1 mutations (see online Table for a complete
list) (Eksandh et al., 2000; Inoue et al., 2000; Mendoza-
Londono et al., 1999; Sato, Oshika, Kaji, & Nose, 2003;Shinoda, Ishida, Oguchi, & Mashima, 2000; Shinoda et al.,
2001; Tanimoto et al., 2002; Tuvdendorj, Isashiki, Ohba,
Sonoda, & Izumo, 2002), but its correlation with ERG Wnd-
ings, if any, has neither been reported nor investigated.
Tapetal-like retinal reXexes characterize also other reti-
nal diseases (reviewed by (Cideciyan & Jacobson, 1994)).
The origin of these reXexes has been studied in female carri-
ers of X-linked retinitis pigmentosa, showing that they
likely originate from photoreceptors (Cideciyan & Jacob-
son, 1994; Berendschot, DeLint, & van Norren, 1996). Reti-
noschisin has been localized to retinal photoreceptors in
several independent studies (Molday et al., 2001; Reid et al.,
1999; Reid & Farber, 2005; Takada et al., 2004; Wang et al.,
2002; Wu & Molday, 2003) and RS1 mutations are pre-
dicted to result most often in defective secretion of retino-
schisin (Wang et al., 2002; Wu & Molday, 2003). We have
provided evidence that also the W112C mutation results in
complete intracellular retention of the mutant protein.
Although caution remains always warranted in assuming
that any in vitro data accounted in full for the entire range
of in vivo pathological eVects of any mutation, this behav-
ior would predict a severe disruption of retinal micro- and
macro-anatomy, as observed in the family reported by
Simonelli et al. (2003). This was clearly not the case in our
subject.
It is therefore conceivable that the mitigating genetic
and/or epigenetic modiWers that account for the overall
mild disease manifestations seen in our patient also allowed
for the retention of retinoschisin in photoreceptor cells to
result in the observed tapetal-like reXex without leading to
overt schitic changes. Its proportionality to the severity of
ERG changes supports the notion that the sheen likely rep-
resents a sub-clinical phenotypic expression of XLRS with
a discernible functional counterpart appreciable at the
ERG level, such that a greater degree of intracellular reten-
tion in photoreceptors would result in a larger adverse
eVect on post-receptoral ERG responses.
Although it has been shown that retinoschisin may
undergo transcytotic transport through Müller cells (Reid
& Farber, 2005), the complete lack of secretion experienced
by the W112C mutant protein argues against any direct
involvement of this putative mechanism in the biogenesis of
the sheen, but does not conclusively rule out the postulated
role of excess extracellular K+ ions suggested by de Jong
et al (de Jong et al., 1991). It remains to be determined
whether the tapetal-like metallic sheen of XLRS is directly
due to photoreceptor intracellular retention of retinoschi-
sin, to mislocalization of the mutant protein at the photore-
ceptor-to-bipolar cell synapse or, in fact, to some entirely
diVerent mechanism linked to lack of extracellular release
of retinoschisin.
5. Conclusions
In summary, we have reported an unusually late-onset
and mild retinal phenotype associated with the W112C
mutation of the RS1 gene. This unique phenotype had not
A. Iannaccone et al. / Vision Research 46 (2006) 3845–3852 3851been previously reported in association with this mutation.
Moreover, we demonstrated that the mutant W112C pro-
tein fails to be secreted from EBNA 293 cells. Continued
functional characterization of clinical XLRS phenotypes,
investigation of the eVects of speciWc mutations on the
intraretinal fate of the mutated protein, and identiWcation
of retinoschisin-interacting proteins in the retina will hope-
fully shed light on the clinical and functional phenotypic
variability of XLRS and reveal in full the pathophysiology
of this protean disorder. An answer to these prevailing
questions may be facilitated by the recent identiWcation of
an ENU-mutagenized mouse line harboring a mutation in
the Rs1h gene with retinal histopathologic features closely
resembling those reported in human XLRS retinas (Jablon-
ski et al., 2005). It will therefore soon become possible to
investigate the in vivo fate of persistent yet defective retino-
schisin production and its eVect on retinal cytoarchitecture
and function in an animal model resembling even more
closely the human scenarios.
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